Heidi Greulich
Broad Institute(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer therapeutics and mechanisms, Cytokine Signaling Pathways and Interactions, Cancer Genomics and Diagnostics
Most-Cited Works
- → EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy(2004)9,380 cited
- → The landscape of somatic copy-number alteration across human cancers(2010)4,082 cited
- → Somatic mutations affect key pathways in lung adenocarcinoma(2008)2,732 cited
- → The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP(2008)2,085 cited
- → Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing(2012)1,820 cited
- → BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models(2008)1,434 cited
- → Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity(2007)1,146 cited
- → Characterizing the cancer genome in lung adenocarcinoma(2007)1,118 cited
- → High-throughput oncogene mutation profiling in human cancer(2007)995 cited
- → Activating mutations in ALK provide a therapeutic target in neuroblastoma(2008)888 cited